- Home
- ARVN vs CTRN Comparison
ARVN vs CTRN Comparison
Compare ARVN & CTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARVN | CTRN |
|---|---|---|
| Founded | 2015 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 600.2M | 559.1M |
| IPO Year | 2018 | 2005 |
Fundamental Metrics
Financial Performance| Metric | ARVN | CTRN |
|---|---|---|
| Price | $6.79 | $43.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 2 |
| Target Price | $14.00 | ★ $91.00 |
| AVG Volume (30 Days) | ★ 859.5K | 212.6K |
| Earning Date | 11-03-2026 | 12-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 58.84 | ★ 112.14 |
| EPS | ★ 0.88 | 0.80 |
| Revenue | $262,600,000.00 | ★ $819,962,000.00 |
| Revenue This Year | $5.67 | $10.94 |
| Revenue Next Year | N/A | $8.69 |
| P/E Ratio | ★ $7.78 | $54.12 |
| Revenue Growth | N/A | ★ 8.88 |
| 52 Week Low | $6.33 | $36.05 |
| 52 Week High | $14.22 | $77.91 |
Technical Indicators
Market Signals| Indicator | ARVN | CTRN |
|---|---|---|
| Relative Strength Index (RSI) | 41.87 | 40.68 |
| Support Level | $6.74 | $42.53 |
| Resistance Level | $7.85 | $52.14 |
| Average True Range (ATR) | 0.47 | 3.53 |
| MACD | -0.03 | -0.28 |
| Stochastic Oscillator | 27.06 | 6.73 |
Price Performance
Historical ComparisonAbout ARVN Arvinas Inc.
Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.
About CTRN Citi Trends Inc.
Citi Trends Inc is a differentiated off-price value retailer known for trendy fashions, great brands and amazing prices. It is the off-price retailer specifically focused on Black customers, delivering the styles, brands, and trends at amazing prices that resonate with its primary and secondary customers. Its product offering is Women's, Men's and Children's apparel, family footwear, accessories and products for the home, with a three-tiered mix of product. At the opening price point, the company offers value-focused basics for its budget-conscious customers.